2Moustapha A,Naso A,Nahiawi M,et al.Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease[J].Circulation,1998,97(2):138-141.
3Cronin CC,Mc Partlin JM,Barry DG,et al.Plasma homocysteine concentrations in patients with type 1 diabetes[J].Diabetes Care,1998,21(11):1843-1847.
5Yilmaz N, Cieek HK, Celik A, et al. Diagnostic value of homocysteine, C-reactive protein and bilirubin for coronary artery disease [J]. East Mediterr Health J, 2007,13(3) :522-535.
6Huh HJ, Chi HS, Shim EH, et al. Gene-nutrition interactions in coronary artery disease:correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population [J]. Thromb Res, 2006,117(5) :501-506.
7Sehadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for mentia and Alzheimer' s disease [ J ]. N Engl J Med, 2002,346(7) :476-478.
8Franken DG, Boers GH, Bolm HJ, et al. Treatment of mild hyperhomocysteinemia in vascular disease patient [ J ]. Arterioseler Thromb, 1994,14(3) :465-470.
9Kathleen P, Graeme JH. The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients:a randomized controlled trail and meta-analysis[J]. Altern Med Rev, 2009,14(1 ) :14-35.
10Omenn GS,Beresford SAA,Motulsky AG.Preventing coronary heart disease:B vitamins and homoeysteine[J].Circulation,1998,97(5):421-424.
